Form D · Other Technology
HYPERSTEALTH BIOTECHNOLOGY CORP
Maple Ridge, A1 · CIK 0001095382
Offering snapshot reported Jun 26, 2013 · SEC filing
- Reported sold
- $19.7K Offering amount: $19.7K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 17, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 26, 2013 | Initial | $19,654 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-198647
13(a) represents the price of the shares (20,000 shares @ C$0.10), converted to US$ based on the exchange rate on the date of closing, June 17, 2013 of US$1.00=C$1.0176.
Source: Form D, filed Jun 26, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Guy Cramer | Director, Executive |
| Gino Gemma | Director |
| Stephen Street | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
Maple Ridge Square, Po Box 21134
Maple Ridge, A1, V2X 1P7
Maple Ridge, A1, V2X 1P7